SAS professional development funding calculation
We would like to highlight the following support documents for our SAS colleagues to take forward when discussing your new contracts or roles.
Read the latest RCOphth news updates and guidance here.
We would like to highlight the following support documents for our SAS colleagues to take forward when discussing your new contracts or roles.
The Royal College of Ophthalmologists is pleased to publish revised guidance on the treatment of Retinopathy of prematurity (ROP). ROP is a potentially blinding condition affecting low gestation and very low birth weight infants. Worldwide, it is a major cause of preventable blindness.
The Government has published the COVID-19 inquiry draft terms of reference. The inquiry will examine, consider and report on preparations and the response to the pandemic in England, Wales, Scotland and Northern Ireland, up to and including the inquiry’s formal setting-up date.
The RCOphth is inviting Age-related Macular Degeneration (AMD) services across the UK to participate and submit data for inclusion in the National Ophthalmology Database (NOD) AMD Audit’s first full data extraction scheduled for May 2022.
RCOphth President Professor Bernie Chang explains the positive action being taken by NHS England through its cataract specification, which the College has supported to develop.
Online applications to the 2022 BMA medical book awards are open and will close on Friday 18 March 2022. The BMA medical book awards take place annually to recognise outstanding contributions to medical literature. There are 15 BMA medical book awards categories available for 2022.
Glaucoma UK, the leading charity in the country for people living with glaucoma, has launched a new easy read guide to help patients put in their eye drops.
Monday 28 February is Rare disease day, a day for raising awareness and generating change for the 300 million people worldwide living with a rare disease, their families and carers. This year the British Ophthalmological Surveillance Unit will celebrate 25 years of rare disease surveillance so today seemed a good opportunity to recognise how this globally unique research unit has impacted the treatment and management of many rare eye conditions. The BOSU has supported over 80 high impact studies of excellent quality that have broadened knowledge and understanding and brought benefit for patients across ophthalmic subspecialties and demographics.
The government and NHS England published a joint plan last week setting out how they intend to support the recovery of elective services over the next three years. RCOphth Policy Manager Jordan Marshall summarises the key implications for ophthalmology services.
The new website provides a comprehensive insight into the world of ophthalmic and vision sciences research and academic ophthalmology careers.